Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Reviews

Liver transplantation for advanced hepatocellular carcinoma

Hae Won Lee, Kyung-Suk Suh

Clin Mol Hepatol. 2016;22(3):309-318. Published online September 25, 2016

Web of Science 25 Crossref 22

DOI: https://doi.org/10.3350/cmh.2016.0042

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy

Ioannis Varbobitis, George V. Papatheodoridis

Clin Mol Hepatol. 2016;22(3):319-326. Published online September 25, 2016

Web of Science 70 Crossref 73

DOI: https://doi.org/10.3350/cmh.2016.0045

Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment

Hyunwoo Oh, Dae Won Jun, Waqar K Saeed, Mindie H Nguyen

Clin Mol Hepatol. 2016;22(3):327-335. Published online September 25, 2016

Web of Science 51 Crossref 52

DOI: https://doi.org/10.3350/cmh.2016.0049

Editorial

Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?

Byoung Kuk Jang

Clin Mol Hepatol. 2016;22(3):336-338. Published online September 25, 2016

Web of Science 2 Crossref 1

DOI: https://doi.org/10.3350/cmh.2016.0104

Original Articles

Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B

Jaemin Lee, Sun Hong Yoo, Won Sohn, Hyung Woo Kim, Yong Sun Choi, Jung Ho Won, Jin Young Heo, Sang Jong Park, Young Min Park

Clin Mol Hepatol. 2016;22(3):339-349. Published online September 25, 2016

Web of Science 19 Crossref 19

DOI: https://doi.org/10.3350/cmh.2016.0021

Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment

Hong Joo Kim, Soo Kyung Park, Hyo Joon Yang, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Kyu Yong Choi

Clin Mol Hepatol. 2016;22(3):350-358. Published online September 25, 2016

Web of Science 1 Crossref 1

DOI: https://doi.org/10.3350/cmh.2016.0019

Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis

Yejoo Jeon, Eun Sun Jang, Yun Suk Choi, Jin-Wook Kim, Sook-Hyang Jeong

Clin Mol Hepatol. 2016;22(3):359-365. Published online September 25, 2016

Web of Science 22 Crossref 21

DOI: https://doi.org/10.3350/cmh.2016.0033

Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection

Jong Man Kim, Kwang-Woong Lee, Gi-Won Song, Bo-Hyun Jung, Hae Won Lee, Nam-Joon Yi, ChoonHyuck David Kwon, Shin Hwang, Kyung-Suk Suh, Jae-Won Joh, Suk-Koo Lee, Sung-Gyu Lee

Clin Mol Hepatol. 2016;22(3):366-371. Published online September 25, 2016

Crossref 1

DOI: https://doi.org/10.3350/cmh.2016.0022

Decreased C-reactive protein induces abnormal vascular structure in a rat model of liver dysfunction induced by bile duct ligation

Ji Hye Jun, Jong Ho Choi, Si Hyun Bae, Seh Hoon Oh, Gi Jin Kim

Clin Mol Hepatol. 2016;22(3):372-381. Published online September 25, 2016

Web of Science 6 Crossref 6

DOI: https://doi.org/10.3350/cmh.2016.0032

Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B

Han Ah Lee, Yeon Seok Seo, Seung Woon Park, Sang Jung Park, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Um

Clin Mol Hepatol. 2016;22(3):382-389. Published online September 25, 2016

Web of Science 18 Crossref 19

DOI: https://doi.org/10.3350/cmh.2016.0047

Case Reports

Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy

Soon Jae Lee, Yoo-Kyung Cho, Soo-Young Na, Eun Kwang Choi, Sun Jin Boo, Seung Uk Jeong, Hyung Joo Song, Heung Up Kim, Bong Soo Kim, Byung-Cheol Song

Clin Mol Hepatol. 2016;22(3):390-395. Published online August 30, 2016

Web of Science 1 Crossref 2

DOI: https://doi.org/10.3350/cmh.2015.0050

A Korean patient with Guillain-Barré syndrome following acute hepatitis E whose cholestasis resolved with steroid therapy

Sung Bok Ji, Sang Soo Lee, Hee cheul Jung, Hong Jun Kim, Hyun Jin Kim, Tae Hyo Kim, Woon Tae Jung, Ok Jae Lee, Dae Hyun Song

Clin Mol Hepatol. 2016;22(3):396-399. Published online August 30, 2016

Web of Science 6 Crossref 8

DOI: https://doi.org/10.3350/cmh.2015.0039

Liver Pathology

Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma

Kyoung-Bun Lee

Clin Mol Hepatol. 2016;22(3):400-405. Published online September 25, 2016

Web of Science 15 Crossref 12

DOI: https://doi.org/10.3350/cmh.2016.0105

Liver Imaging

What we need to know when performing and interpreting US elastography

So Hyun Park, So Yeon Kim, Chong Hyun Suh, Seung Soo Lee, Kyoung Won Kim, So Jung Lee, Moon-Gyu Lee

Clin Mol Hepatol. 2016;22(3):406-414. Published online September 25, 2016

Web of Science 40 Crossref 40

DOI: https://doi.org/10.3350/cmh.2016.0106

Viewed By 4934	MAFLD: How is it different from NAFLD?
Viewed By 4828	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4728	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4446	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4402	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 214	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 133	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 117	MAFLD: How is it different from NAFLD?
Cited By 95	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Previous issues